Asia Pacific eClinical Solutions market

Japan accounted for the largest market share in 2017 in the asia pacific eclinical solutions market, and is expected to reach usd 513.24 million in 2023 from usd 249.88 million in 2017. however, india is the fastest growing market, which is expected to grow at a cagr of 14.13% during the forecast period 2018 - 2023. web based and cloud based segment accounted for the larger market share in 2017, this market is expected to reach usd 1168.62 million in 2023 from usd 541.48 million in 2017. this market is projected to grow at a cagr of 13.60% during the forecast period from 2018 - 2023. however, web based and cloud based segment is the fastest growing market, which is expected to grow at a cagr of 13.60% during the forecast period 2018 - 2023. clinical data management system segment accounted for the largest market share in 2017, this market is expected to reach usd 496.59 million in 2023 from usd 218.23 million in 2017. this market is projected to grow at a cagr of 14.61% during the forecast period from 2018 - 2023. however, electronic clinical outcome assessment segment is the fastest growing market, which is expected to grow at a cagr of 15.62% during the forecast period 2018 - 2023. phase iv segment accounted for the largest market share in 2017, this market is expected to reach usd 747.17 million in 2023 from usd 367.36 million in 2017. this market is projected to grow at a cagr of 12.48% during the forecast period from 2018 - 2023. however, phase i segment is the fastest growing market, which is expected to grow at a cagr of 14.28% during the forecast period 2018 - 2023. contract research organizations segment accounted for the largest market share in 2017, this market is expected to reach usd 887.43 million in 2023 from usd 410.91 million in 2017. this market is projected to grow at a cagr of 13.61% during the forecast period from 2018 - 2023. however, contract research organizations segment is the fastest growing market, which is expected to grow at a cagr of 13.61% during the forecast period 2018 - 2023.